TI
CRMD icon

Tidal Investments’s CorMedix CRMD Stock Holding History

Tidal Investments’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,024
Closed -$52.1K – 1859
2024
Q2 		$52.1K Sell
12,024
-2,081
-15% -$10.6K ﹤0.01% 1766
2024
Q1 		$59.8K Buy
+14,105
New +$48.9K ﹤0.01% 1628

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tidal Investments's CRMD Position: Q3 2024 in Review

Tidal Investments sold out of CorMedix (CRMD) in Q3 2024, closing a stake of 12,024 shares — an estimated $52.1K sold.

Tidal Investments first reported a position in CRMD in Q1 2024 and held it in 2 quarters. The position peaked at $59.8K in Q1 2024. 102 funds tracked by Wall St. Rank hold CRMD as of Q3 2024.

  • Tidal Investments reported no remaining CorMedix position as of Q3 2024 after selling out during the quarter.
  • Tidal Investments sold 12,024 CorMedix shares in Q3 2024, an estimated $52.1K.
  • Tidal Investments first reported a position in CorMedix in Q1 2024 and held it in 2 quarters.
  • Tidal Investments's CorMedix position peaked at $59.8K in Q1 2024.
  • 102 funds tracked by Wall St. Rank held CorMedix as of Q3 2024.

Based on Tidal Investments's 13F filing for Q3 2024, filed 14 Nov 2024.